Missling Christopher U

President and CEO, DirectorANAVEX LIFE SCIENCES CORP. (AVXL) · full profile →Form 4 · filed Jun 30, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.1M
Net Open-Market Flow
-$2.1M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2023Option exercise(M)232K$1.60$371K1.3M
Jun 28, 2023Sell(S)268K$7.98$2.1M1.0M
Jun 28, 2023Option exercise(M)268K$1.60$429K1.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2023Option exercise(M)232K$00
Jun 28, 2023Option exercise(M)268K$0232K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001731122-23-001246) within minutes of acceptance. Every field above traces to the original document. Verify it directly: